Veeva Systems Inc.

NYSE:VEEV Stock Report

Market Cap: US$34.2b

Veeva Systems Valuation

Is VEEV undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of VEEV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
US$245.02
Fair Value
11.9% undervalued intrinsic discount
30
Number of Analysts

Below Fair Value: VEEV ($215.78) is trading below our estimate of fair value ($245.02)

Significantly Below Fair Value: VEEV is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for VEEV?

Key metric: As VEEV is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for VEEV. This is calculated by dividing VEEV's market cap by their current earnings.
What is VEEV's PE Ratio?
PE Ratio49.2x
EarningsUS$714.14m
Market CapUS$34.18b

Price to Earnings Ratio vs Peers

How does VEEV's PE Ratio compare to its peers?

The above table shows the PE ratio for VEEV vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average75x
DOCS Doximity
48.8x13.3%US$9.6b
GDRX GoodRx Holdings
104.2x28.6%US$1.7b
HSTM HealthStream
49.1x4.6%US$967.0m
SLP Simulations Plus
98x39.2%US$681.8m
VEEV Veeva Systems
49.2x14.6%US$34.2b

Price-To-Earnings vs Peers: VEEV is good value based on its Price-To-Earnings Ratio (49.2x) compared to the peer average (75x).

Price to Earnings Ratio vs Industry

How does VEEV's PE Ratio compare vs other companies in the Global Healthcare Services Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
VEEV 49.2xIndustry Avg. 32.2xNo. of Companies8PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: VEEV is expensive based on its Price-To-Earnings Ratio (49.2x) compared to the Global Healthcare Services industry average (32.2x).

Price to Earnings Ratio vs Fair Ratio

What is VEEV's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

VEEV PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio49.2x
Fair PE Ratio33.9x

Price-To-Earnings vs Fair Ratio: VEEV is expensive based on its Price-To-Earnings Ratio (49.2x) compared to the estimated Fair Price-To-Earnings Ratio (33.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst VEEV forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$215.78
US$263.14
+21.9%
9.0%US$290.00US$201.00n/a30
Apr ’26US$227.90
US$266.54
+17.0%
9.4%US$307.00US$201.00n/a30
Mar ’26US$224.14
US$265.43
+18.4%
11.2%US$320.00US$195.00n/a30
Feb ’26US$233.26
US$265.43
+13.8%
11.2%US$320.00US$195.00n/a30
Jan ’26US$210.25
US$268.67
+27.8%
9.8%US$320.00US$195.00n/a30
Dec ’25US$227.85
US$248.57
+9.1%
11.4%US$286.00US$173.00n/a28
Nov ’25US$212.78
US$234.63
+10.3%
10.7%US$286.00US$173.00n/a27
Oct ’25US$207.62
US$233.48
+12.5%
10.0%US$281.00US$173.00n/a27
Sep ’25US$216.44
US$231.08
+6.8%
10.1%US$281.00US$173.00n/a27
Aug ’25US$189.14
US$222.34
+17.6%
11.0%US$270.00US$173.00n/a27
Jul ’25US$181.67
US$222.32
+22.4%
11.6%US$270.00US$173.00n/a26
Jun ’25US$174.25
US$227.41
+30.5%
11.9%US$270.00US$173.00n/a25
May ’25US$198.90
US$241.81
+21.6%
8.0%US$270.00US$200.00n/a27
Apr ’25US$230.39
US$240.99
+4.6%
8.1%US$270.00US$200.00US$227.9028
Mar ’25US$222.01
US$232.50
+4.7%
11.0%US$270.00US$160.00US$224.1428
Feb ’25US$203.99
US$213.46
+4.6%
11.4%US$267.00US$160.00US$233.2626
Jan ’25US$192.52
US$211.81
+10.0%
11.0%US$267.00US$160.00US$210.2527
Dec ’24US$178.84
US$216.30
+20.9%
11.5%US$267.00US$160.00US$227.8527
Nov ’24US$187.05
US$227.33
+21.5%
9.2%US$275.00US$181.00US$212.7827
Oct ’24US$203.45
US$225.04
+10.6%
9.2%US$275.00US$181.00US$207.6225
Sep ’24US$216.57
US$222.62
+2.8%
9.0%US$275.00US$181.00US$216.4426
Aug ’24US$202.75
US$214.19
+5.6%
11.2%US$275.00US$170.00US$189.1427
Jul ’24US$197.73
US$212.00
+7.2%
11.1%US$275.00US$170.00US$181.6726
Jun ’24US$198.30
US$209.77
+5.8%
11.7%US$275.00US$170.00US$174.2526
May ’24US$180.00
US$209.00
+16.1%
11.1%US$275.00US$170.00US$198.9025
Apr ’24US$183.79
US$209.28
+13.9%
11.1%US$275.00US$170.00US$230.3925
AnalystConsensusTarget
Consensus Narrative from 30 Analysts
US$263.14
Fair Value
18.0% undervalued intrinsic discount
30
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/22 22:07
End of Day Share Price 2025/04/22 00:00
Earnings2025/01/31
Annual Earnings2025/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Veeva Systems Inc. is covered by 45 analysts. 30 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph VruwinkBaird
Ishan MajumdarBaptista Research
Saket KaliaBarclays